top of page
HOME
ABOUT US
AURASE WOUND GEL
The Problem
Our Solution
Clinical Evidence
R&D Development Plan
NEWS
PUBLICATIONS
CONTACT
18/08/21, 11:00
Seneca Partners invests £1.2m into biotech start-up SolasCure
Previous
Next
HOME
ABOUT US
AURASE WOUND GEL
The Problem
Our Solution
Clinical Evidence
R&D Development Plan
NEWS
PUBLICATIONS
CONTACT
bottom of page